Schedule 13D ownership disclosure
Asterias Biotherapeutics, Inc.
Security class unavailable · CUSIP: 04624N107
Event date: 2014-04-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 24,973,340
- Percent of class
- 79.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-14-016535
- Form type
- SC 13D
- Filer
- Asterias Biotherapeutics, Inc.
- CIK
- CIK 1572552
- Filed
- Apr 11, 2014
- Reporting period
- Apr 09, 2014
- Description
- Schedule 13D beneficial ownership